[1]
Retinasamy, T. and Shaikh, M.F. 2021. Aducanumab for Alzheimer’s disease: An update. Neuroscience Research Notes. 4, 2 (Jun. 2021), 17–20. DOI:https://doi.org/10.31117/neuroscirn.v4i2.81.